Cannara Biotech Inc. Operating Cash Flow for the year ending August 31, 2024: USD 7.92 M

Cannara Biotech Inc. Operating Cash Flow is USD 7.92 M for the year ending August 31, 2024, a 96.84% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Cannara Biotech Inc. Operating Cash Flow for the year ending August 31, 2023 was USD 4.02 M, a -186.93% change year over year.
  • Cannara Biotech Inc. Operating Cash Flow for the year ending August 31, 2022 was USD -4.63 M, a 178.91% change year over year.
  • Cannara Biotech Inc. Operating Cash Flow for the year ending August 31, 2021 was USD -1.66 M, a -76.78% change year over year.
  • Cannara Biotech Inc. Operating Cash Flow for the year ending August 31, 2020 was USD -7.14 M, a 28.91% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities